AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PIRFENIDONE
13 registrations across 5 African markets— 12 active
Markets with PIRFENIDONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FENIFIB 267 Film-coated tablets, | 🇷🇼Rwanda | — | active | May 2031 |
| FENIFIB 801 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Apr 2031 |
| FENIFIB 267 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Apr 2031 |
| FENIFIB 801 Film-Coated Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | Jan 2031 |
| FENIFIB 267 Film-Coated Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | Jan 2031 |
| PIROFIBRA 267 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Feb 2029 |
| PIRFENIDONE 267 CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Feb 2029 |
| PIRFENIDONE 801 CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Feb 2029 |
| PIROFIBRA 801 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Feb 2029 |
| ESBRIET 267 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jul 2028 |
| ESBRIET 801 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jul 2028 |
| PIRFENBET 200MG 200MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | BETAM LABORATORIES PRIVATE LIMITED | expired | Oct 2024 |
| ESBRIET | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
PIRFENIDONE in Africa — Regulatory Overview
PIRFENIDONE is registered across 5 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Zimbabwe, Côte d'Ivoire and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 13 registrations, 12 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.